Literature DB >> 19188510

Fasting blood glucose and the risk of stroke and myocardial infarction.

Joohon Sung1, Yun-Mi Song, Shah Ebrahim, Debbie A Lawlor.   

Abstract

BACKGROUND: Although diabetes is a well-known risk factor of atherosclerotic cardiovascular diseases, the cardiovascular disease risk of glycemia below the current diabetic threshold remains uncertain. METHODS AND
RESULTS: A total of 652,901 Korean men aged 30 to 64 years from the Korean National Health Insurance System were categorized into 8 groups by fasting blood glucose (FBG) level at baseline and were followed up for cardiovascular diseases occurrence during 1992-2001. Over the follow-up period of 8.8 years, 10,954 stroke and 3766 myocardial infarction events occurred. In age-adjusted analyses, there was evidence of linear associations between FBG and myocardial infarction, ischemic stroke, and intracerebral hemorrhagic stroke. However, with additional adjustment for socioeconomic position, behaviors, and other cardiovascular disease risk factors, the associations with myocardial infarction and intracerebral hemorrhagic stroke were markedly attenuated with increased risk only at the highest FBG levels (> or =7.5 mmol/L). With full adjustment, the association with ischemic stroke persisted; a linear increase in the risk of ischemic stroke was observed from FBG level of 5.6 mmol/L. When the analyses were repeated with those persons who had been diagnosed with diabetes removed, there was no evidence of associations of FBG with intracerebral hemorrhagic stroke, but the association with ischemic stroke persisted.
CONCLUSIONS: In this Korean male population, the association with high FBG differed between ischemic stroke, intracerebral hemorrhagic stroke, and myocardial infarction. The linear increase in the risk of ischemic stroke, independently of other cardiovascular risk factors, was observed at a level below the current FBG criteria for impaired fasting glucose (> or =5.6 mmol/L). However, for other cardiovascular diseases, the current cutoff for diagnosing diabetes appropriately identified Korean men at risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188510     DOI: 10.1161/CIRCULATIONAHA.108.776989

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

1.  Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.

Authors:  C-L Huang; H-W Chang; J-B Chang; J-H Chen; J-D Lin; C-Z Wu; D Pei; Y-J Hung; C-H Lee; Y-L Chen; C-H Hsieh
Journal:  QJM       Date:  2015-11-16

2.  Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach.

Authors:  Felipe A de Oliveira; Mohamed H Shahin; Yan Gong; Caitrin W McDonough; Amber L Beitelshees; John G Gums; Arlene B Chapman; Eric Boerwinkle; Stephen T Turner; Reginald F Frye; Oliver Fiehn; Rima Kaddurah-Daouk; Julie A Johnson; Rhonda M Cooper-DeHoff
Journal:  Metabolomics       Date:  2016-07-13       Impact factor: 4.290

3.  Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up.

Authors:  David Preiss; Paul Welsh; Heather M Murray; James Shepherd; Chris Packard; Peter Macfarlane; Stuart Cobbe; Ian Ford; Naveed Sattar
Journal:  Eur Heart J       Date:  2010-04-15       Impact factor: 29.983

4.  Fasting blood glucose levels affect hospitalization time and relapse and mortality rates of cerebral infarction patients.

Authors:  Yi Cao; Fei Wang; Qianpeng Cheng; Xiumin Jiao; Xiaofeng Lv
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

Review 6.  Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Authors:  Nadeem Sarwar; Thor Aspelund; Gudny Eiriksdottir; Reeta Gobin; Sreenivasa Rao Kondapally Seshasai; Nita G Forouhi; Gunnar Sigurdsson; John Danesh; Vilmundur Gudnason
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

7.  Renal functional impairment in the elderly, the importance of fasting plasma glucose: the Northern Shanghai Study.

Authors:  Ximin Fan; Jiadela Teliewubai; Jing Xiong; Chen Chi; Yuyan Lu; Mengyun Zhu; Yi Zhang; Yawei Xu
Journal:  Aging Clin Exp Res       Date:  2020-03-21       Impact factor: 3.636

8.  Fasting glucose levels within the high normal range predict cardiovascular outcome.

Authors:  Kivity Shaye; Tirosh Amir; Segev Shlomo; Sidi Yechezkel
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

9.  Association of prediabetes and diabetes with stroke symptoms: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  April P Carson; Paul Muntner; Brett M Kissela; Dawn O Kleindorfer; Virginia J Howard; James F Meschia; Linda S Williams; Ronald J Prineas; George Howard; Monika M Safford
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

10.  Effects of Stress Hyperglycemia on Short-Term Prognosis of Patients Without Diabetes Mellitus in Coronary Care Unit.

Authors:  Luming Zhang; Zichen Wang; Fengshuo Xu; Didi Han; Shaojin Li; Haiyan Yin; Jun Lyu
Journal:  Front Cardiovasc Med       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.